Evidence map›Paper›PMID 42379498›Full record

ReviewJournal of sport and health science2026

Optimal exercise strategies to improve HDL-C in metabolic syndrome: A systematic review with pairwise, network, and dose-response meta-analysis.

Huimin Ding, Liqun Jiang, Dongjun Lee, Buongo Chun

Abstract readReview
In one paragraph

Review in Journal of sport and health science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Huimin DingGraduate School of Physical Education, Myongji University, Yongin 17058, Republic of Korea.
Liqun JiangGraduate School of Physical Education, Myongji University, Yongin 17058, Republic of Korea.
Dongjun LeeGraduate School of Physical Education, Myongji University, Yongin 17058, Republic of Korea.
Buongo ChunGraduate School of Physical Education, Myongji University, Yongin 17058, Republic of Korea. Electronic address: tianbingwu@mju.ac.kr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundReduced high-density lipoprotein cholesterol (HDL-C) is a hallmark metabolic abnormality in metabolic syndrome (MetS). Exercise is widely recommended to improve HDL-C, but the optimal modality and dose remain uncertain.

methodsThis systematic review and network meta-analysis (NMA) followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and Cochrane guidelines and was prospectively registered in PROSPERO (CRD420251049084). Five databases were searched through November 17, 2025. The NMA compared continuous aerobic exercise (CAE), high-intensity interval training (HIIT), resistance training (RT), combined aerobic-resistance exercise (CAREX), and mind-body exercise (MBE). Dose-response NMA (DR-NMA) using restricted cubic splines modeled multidimensional exercise doses derived from metabolic equivalent of task (MET)-min/week, % maximal oxygen uptake (VO₂

resultsFifty-six randomized controlled trials comprising 3788 individuals with MetS were included. HIIT ranked as the most effective modality for raising HDL-C, with the highest surface under the cumulative ranking curve value (SUCRA = 86%), producing an increase of 0.08 mmol/L when performed at 750-1500 MET-min/week and 80%-90% VO₂

conclusionExercise effectively improves HDL-C in individuals with MetS, with HIIT and CAREX offering the greatest benefits. Clear optimal dose ranges were identified across physiological load indicators, underscoring the need for individualized, dose-precise exercise prescriptions to optimize HDL-C improvement.

Indexed as

Dose–responseExerciseHigh-density lipoprotein cholesterolMetabolic syndrome

Identifiers

PMID42379498
PMCPMC13636440

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.